Harmony Biosciences

Harmony Biosciences

Biopharmaceutical company and a member of the Paragon Biosciences corporate family.

HQ location
Upper Merion Township, United States
Website
harmonybiosciences.com
Launch date
Employees
201-500 people
Market cap
$1.8b
Enterprise value
$1.5b
Share price
$31.60 HRMY
Jobs
View job openings
Recent deals
https://twitter.com/harmonybiohttps://www.linkedin.com/company/harmonybiosciences
    • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor

€0.0

round
investor investor investor investor investor investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
N/A

€0.0

Valuation: €0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
investor

€0.0

round
*
N/A

N/A

Post IPO Equity
Total Funding000k
Valor Equity Partners
Valor Equity Partners(exited)
Fidelity Investments
Fidelity Investments(exited)
Vivo Capital
Vivo Capital(exited)
venBio Partners
venBio Partners(exited)
Novo Ventures
Novo Ventures(exited)
Nan Fung Group
Nan Fung Group(exited)
Novo Holdings
Novo Holdings(exited)
Aisling Capital
Aisling Capital(exited)
CRG LP
CRG LP(exited)
HBM Healthcare Investments
HBM Healthcare Investments(exited)
OrbiMed
OrbiMed(exited)
Blackstone
Blackstone(exited)
HBM Partners
HBM Partners(exited)
International Biotechnology Trust
International Biotechnology Trust(exited)
JPMorgan Chase & Co
JPMorgan Chase & Co(exited)
Victory Capital Management
Victory Capital Management(exited)
Paragon Biosciences
Paragon Biosciences(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth91 %43 %33 %23 %18 %18 %17 %
EBITDA0000000000000000000000000000
% EBITDA margin29 %27 %40 %33 %36 %36 %36 %
Profit0000000000000000000000000000
% profit margin11 %41 %22 %20 %23 %25 %26 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue10 %16 %13 %20 %---

Source: Company filings or news article, Equity research estimates

Related Content

More about Harmony Biosciences
Made with AI
Edit

Harmony Biosciences is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases. The company operates in the healthcare sector, specifically targeting conditions that have limited treatment options. Harmony Biosciences serves patients, healthcare providers, and the broader medical community by bringing breakthrough science within reach. The business model revolves around the research, development, and commercialization of novel medications, generating revenue through the sale of these specialized therapies. The company invests heavily in scientific research to identify new clinical possibilities and advance the treatment landscape for rare neurological disorders.

Keywords: biopharmaceutical, rare diseases, neurological, innovative therapies, commercialization, healthcare, research, development, novel medications, breakthrough science.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Harmony Biosciences

Edit
Zynerba Pharmaceuticals (Formerly AllTranz)
Zynerba Pharmaceuticals (Formerly AllTranz)
ACQUISITION by Harmony Biosciences Aug 2023
Epygenix
Epygenix
ACQUISITION by Harmony Biosciences Apr 2024